We report that endogenous regulatory factors
The CyIIIa cytoskeletal actin gene of Strongylocentrotus purpuratus (1, 2) provides a marker of the process of differential gene expression by which the embryo constructs its initial sets of specialized cell lineages. The gene is transcriptionally activated 10-12 hr postfertilization (3) (4) (5) and is expressed throughout embryonic development, exclusively in the six cell lineages from which derive the aboral ectoderm of the completed pluteus (6) (7) (8) . A fusion construct consisting of the chloramphenicol acetyltransferase (CAT; acetyl-CoA:chloramphenicol 03-acetyltransferase, EC 2.3.1.28) reporter gene under the control of upstream CyIIIa sequences (CyIIIa-CAT fusion gene) has been microinjected into unfertilized eggs (9) . A regulatory domain that includes necessary and sufficient cis-acting sites to promote CAT expression on the correct developmental schedule (10) , and exclusively in cells of the correct lineages (11, 12) , can thus be identified. The CyIIIa regulatory domain extends for about 2.5 kilobases (kb) upstream ofthe locus oftranscription initiation (refs. 3 and 10; F. Calzone, N. Thez6, and E.H.D., unpublished data). Reactions carried out in vitro with probes spanning this region demonstrate at least 11 different sequence-specific interactions with DNA-binding proteins present in extracts from nuclei of blastula-stage embryos in which the CyIlIa gene is active (ref. 13 ; N. Thdzd, F. Calzone, and E.H.D., unpublished data). The stoichiometry of DNAprotein complex formation in these extracts provides estimates of the equilibrium parameters that govern these interactions in vitro and also of the approximate minimum prevalences in the blastula nuclear extracts for each of the respective DNA-binding factors (13) (14) (15) . The biological significance of several of these specific interactions is indicated by additional gene transfer experiments in which excess quantities of individual subfragments of the regulatory domain were coinjected with the complete Cylla-CAT fusion construct (R. Franks, R. Anderson, B. Hough-Evans, and E.H.D., unpublished data). Thus competition by certain subfragments that include particular interaction sites identified in vitro severely depresses CAT expression in transgenic embryos and, in at least one case, appears to affect spatial regulation as well. To summarize, current evidence supports the conclusion that some of the DNA-protein interactions observed in vitro constitute the casual events that produce the temporal and spatial regulation of the CyIIIa gene.
The present work was undertaken to obtain estimates of the available concentration of the limiting factor(s) in vivo.
We have varied the number of Cylla-CAT fusion genes stably incorporated per embryo nucleus and have measured the consequent output of CAT enzyme. We first show that, as implied by our earlier study (10) , the regulatory system is effectively saturated when about 1500 copies of the CyIIIaCATgene are injected per egg. Thus CAT enzyme production in blastula-stage embryos raised from these eggs is almost stoichiometrically decreased by coinjection of various amounts of the upstream CyIIIa regulatory domain. We then report measurements of CAT enzyme production as a function of the number of copies of the Cyllia-CAT gene incorporated for several different batches of eggs. These measurements demonstrate the, saturation behavior of the limiting factor(s) in vivo and thus provide an approximate estimate of the number of such factor molecules available per nucleus. Finally, we compare this estimate with those obtained previously from in vitro measurements of factor prevalence in crude nuclear extracts of embryos expressing the CyIIIa gene (13) .
MATERIALS AND METHODS
Micro'N ection of Eggs with Carrier and Competitor DNA Solutions. S. purpuratus eggs were microinjected and subsequently cultured as previously described (9, 10) . The aggregate concentration of the injected DNAs was held constant within each experiment, at about 56 ,ug/ml. Sperm DNA prepared as previously described (1) precipitated. This protocol yielded carrier DNA with Sph I termini and with an average length of -10 kb, [i.e., only slightly below the length of the CyIIIa-CATconstruct utilized (14 kb)]. The fragments of the CyIIIa-CAT used for competition experiments were prepared by digestion with the appropriate restriction enzyme, as indicated, followed by separation by electrophoresis through an 0.8% agarose gel and purified by elution from DE81 filters.
Other Procedures. All other procedures were carried out as previously described (10) .
RESULTS
Near-Stoichiometric Competition in Vivo by Cyllia Regulatory Sequences at a Saturating Level of Cyllla-CAT Genes. The study of Flytzanis et al. (10) demonstrated that a more or less constant amount of CAT enzyme is produced by embryos raised from eggs injected with various quantities of CyllIa-CAT DNA, ranging from a few hundred to thousands of molecules per egg. It was proposed that within this range the number of copies of the CyIlla regulatory sequence incorporated is probably saturating for regulatory factors available at limited concentrations within the blastula nuclei (10) . Linear DNA molecules injected into sea urchin egg cytoplasm are rapidly ligated into end-to-end concatenates, irrespective of the terminal sequences. In most embryos, these are stably incorporated into one or a few blastomere nuclei after the third to fifth cleavage, which results in a mosaic pattern of exogenous DNA retention that is apparently random with respect to embryonic cell lineage (9, 10, 12, 16, 17) . After incorporation, the exogenous DNA replicates at approximately the rate of the genomes of the host cells. Significant loss of DNA does not occur during embryogenesis. Thus, if several thousand molecules of DNA are injected into the unfertilized egg, this number of copies of the injected sequence may be stably retained in all the cells descendant from the blastomere(s) in which the initial incorporation event took place.
If the amount of CAT expression in such embryos is indeed limited by regulatory factor availability and the CylI~a-CAT genes are present in excess, then coinjection of additional copies of the upstream CyIla regulatory domain together with the complete CyIIIa-CAT reporter fusion construct should competitively reduce CAT enzyme expression. Furthermore, competition should occur at relatively low molar ratios of competitor to CyIIla-CAT sequence, and the amount of competition should stoichiometrically reflect the incorporated competitor/fusion gene ratios. To explore these predicted consequences experimentally, we injected eggs with 1500 molecules of the CyIIa-CAT fusion gene, together with varying numbers of molecules of subfragments containing the whole Cy~lla regulatory domain. Linearized carrier DNA terminating in Sph I ends, as does the linearized CyIlIa-CAT construct, were coinjected in quantities adjusted so that the total mass of injected DNA remained constant at 0.1 pg. molecules produced per embryo is given as a function of the molar ratio of competitor to CyIlIa-CAT genes injected (e.g., for the ratio of 5, 7500 molecules of the Sph I-BamHI fragment were coinjected with 1500 molecules of the CyIla-CAT gene, together with about 6200 molecules of carrier DNA). Note that the two different 5' CyIIIa gene fragments used compete similarly despite their >3-fold difference in length and the fact that the 2.7-kb Sph I-BamHI fragment has a terminus homologous with the CyIIIa-CAT DNA termini (and the carrier DNA termini), whereas the 9.3-kb fragment does not. The dashed line in Fig. lb shows the ideal results that would have been obtained had reduction in CAT activity occurred with perfect stoichiometry with respect to the number of Cyflla 5' flanking sequences present. The experimental data fit by the solid line indicate that the competition behaves as if about 40%o of the competing DNA were effective, rather than all of it. There are several possible interpretations, the most likely of which is that in some embryos of each batch concatenates containing competing DNA and little or no CyIIa-CAT DNA were formed and incorporated in different cells from the bulk of the CyllIa-CAT DNA. It is also possible that for some reason the competing DNA was marginally less likely to be engaged in concatenates in the first place. This small difference from ideal stoichiometry aside, however, Fig. lb provides clear evidence of systematic competition in vivo, at the modest competitor/reporter gene ratios expected. Thus, for example, at a competitor/reporter gene ratio of only 5:1, activity is reduced to about 30o of the control value. This behavior requires that the CyIIIa-CAT reporter gene is in fact close to, if not at, saturation with respect to at least the limiting intranuclear factor(s) required for CAT expression.
Saturation of CylIla-CAT Expression in Transgenic Embryos. Measurements of CAT expression in samples of 24-hr embryos bearing increasing numbers of CyIlIIa-CAT genes were carried out on single batches of eggs. We were aware from earlier studies (10, 12) that given batches display variable abilities to concatenate, incorporate, and thence amplify the injected DNA. The eggs were all injected with a total mass of about 0.1 pg of DNA. Of this, at least 80% was carrier DNA (i.e., about 7500 molecules per egg at the nominal 10-kb length of the carrier preparation), and the remainder consisted of various amounts of the 14-kb CyIIIa-CAT fusion gene plus sufficient carrier to achieve the equivalent of 0.1 pg of injected DNA mass in all samples. Thus individual eggs received from 30 to 1500 copies ofthe CyIIIa-CATconstruct, and all samples contained at least a 5-fold molar excess ofcarrier. The addition of a modest molar excess of carrier DNA has been found to increase CAT expression several fold in embryos bearing the CyIIIa-CAT fusion, possibly by providing spacers between adjacent CyIIIa-CAT molecules in the incorporated concatenates (ref. 17; R. Franks and E.H.D., unpublished data). Maximum expression is always attained at the .5-fold molar excess of carrier DNA/CyIIIa-CAT DNA utilized in these experiments. The experimental design thus ensures that the only systematic variable affecting CAT expression will be the number of incorporated CyIlIa-CAT genes in the various samples of each experiment. This was calculated from direct measurements of CAT DNA sequence content in aliquots of the experimental embryos, obtained by slot blot hybridization with a CAT sense-strand 32P-labeled RNA probe (see legend to Fig. 2 ). CAT enzyme content was also measured in extracts ofeach sample ofembryos, and the average amount ofenzyme in the cells producing it (i.e., those aboral ectoderm cells bearing the exogenous DNA) was calculated. To derive this value, we applied a measurement recently obtained by HoughEvans et al. (12) , who found by in situ DNA hybridization that a mean of 6% of the total cells of 24-hr embryos grown from eggs cytoplasmically injected with CyIIIa-CAT bear stably incorporated exogenous DNA concatenates. When the small fraction of eggs in each sample that received or retained no DNA whatsoever, due to unsuccessful injection, is included in the embryo pools as in this work, the mean fraction of cells in the total sample bearing the exogenous DNA is about 5%. This result was independently confirmed for two of the batches of eggs utilized for the present experiments, which were assayed by the same in situ DNA hybridization method (data not shown). Since -200 of the cells of the~=500-cell 24-hr embryo belong to the aboral ectoderm lineages and are capable of expressing CyIlla-CAT (6-8, 11, 12), CAT enzyme content per average expressing cell should be about 1o of the total CAT enzyme content per 24-hr embryo.
Saturation curves depicting CAT production as the number of CylIla-CAT genes is increased are shown in Fig. 2a [2] Here the saturation values can be obtained from the intercepts CAT, CAT enzyme molecules; sat., saturation.
*Each batch of eggs was obtained from a different female except for 5a and Sb, which both derived from the same female. The batches of eggs (female number) correspond to the experiments in Fig. 2a tG05. and G0.9 represent genes per cell (average) for 50o and 90%
saturation, respectively, given the least-squares solutions for CO and k and assuming Eq. I. tParameters derived from linear least-squares reductions of the data shown assuming Eq. 2.
refs. 12 and 17)]. Table 1 shows that the half-saturating number of CyIIIa-CAT sequences per cell (Go.5) is 105 + 40 genes (mean + SD). The variation in these data is little greater than the variation between the two sibling experiments shown in Fig. 2a (experiments 5a and Sb). The excellent fit of the data for all batches to the form of Eq. 1 or 2 demonstrates that as the number of CyIIIa-CA Tgenes per cell increases, the output of CAT enzyme indeed follows saturation behavior, and thus the incorporated genes can be considered to be titrating out cellular factor(s) needed to express this sequence. Since 50% saturation is approached at only about 102 genes per cell, whereas the same cells are probably expressing at least 1-2 x 104 diverse transcription units (18) , it is obvious that the saturation observed is a phenomenon that pertains to CylIla or a small class of genes that might require the same factors. It follows that the saturation functions shown in Fig. 2 represent titrations of a limiting set of sequence-specific factors required for Cyilla expression. DISCUSSION The titration described here provides an absolute index ofthe molecular availability of the limiting factors required for CyIlla-CAT expression. We assume in the following that these are sequence-specific transcription factors, since the coinjected upstream regulatory sequences of the Cyl~la gene compete efficiently with the CylIIa-CA Tfusion gene. Similar results were obtained from other unpublished experiments (cited in the Introduction) in which small subfragments of the upstream sequence that include no transcribed or translated sequence whatsoever were coinjected. However, there is no formal proof that the results of the titration experiments are not affected by competition for specific, rare, translation factors, a possibility that we nonetheless discard on grounds of improbability. The efficient competition shown in Fig. 1 obviously cannot be explained on this basis since all samples contain the same amount of translatable sequence. Competition for general translation as well as transcription factors is precluded because the CAT transcripts are only a few percent of the total nuclear transcripts and, similarly, because CAT protein translation per se represents only a few percent of the total embryo protein synthesis. Thus Flytzanis et al. (10) calculated that the half-life of CAT enzyme in sea urchin embryos is about 40 min, and, from this and the maximum steady-state levels of CAT enzyme per cell shown in Table 1 of which fall between 5 x 10' and 106, 90%o and 50%, respectively, of the factor(s) would be found associated with the nonspecific sites, were equilibrium conditions to prevail. For example were Kr = 106, the total number of factor molecules of that species would be about 2100 per nucleus, of which half (1055) are bound to specific and half to nonspecific sites. However, the total amount of available nonspecific DNA per nucleus is most probably much less than 30%o of the total base pairs in the diploid genome (14, 15) , and thus the fraction offactor molecules bound to nonspecific DNA will in actuality be less. In any case, this heuristic argument shows that the amount of factor per nucleus should fall within a few fold of the total number of sites actually bound per nucleus as the saturation curves in our experiments approach their maximum. Our previous measurements offactor prevalence in nuclear extracts in vitro (13) This result implies that DNA-binding factor prevalences, measured in vitro for DNA-protein interactions at equilibrium, may be referred to regulatory binding interactions in life. The general implication, which remains to be directly tested, is that the concentrations of bound and free regulatory sites and nonspecific sites are all at equilibrium within the nucleus. Our experiments show that there is no very large reservoir of extractable binding factor irreversibly associated with nonspecific sites (i.e., beyond those factor molecules that can be stolen from nonspecific sites as high-affinity sites are added). Calzone et al. (13) estimated a half-life for the proteinnonspecific DNA complexes bound by the CyIlla factors in vitro of the order of a few milliseconds, and these complexes must be highly unstable in vivo as well. Thus, it is reasonable to conclude that the Kr values in vivo are not greatly lower than those we measured in vitro. They could be higher, however, and thus it is not yet clear whether once formed the specific DNA-protein complexes in vivo are also as unstable as observed in vitro. As measured in the crude nuclear extracts, the half-lives of these ranged from several minutes to close to an hour, and on present evidence it cannot be excluded that in living nuclei such complexes are "locked" into more stable configurations. However, the results we report permit the possibility that the specific as well as the nonspecific interactions within the nucleus behave more or less as expected from equilibrium considerations in vitro. The active state of a gene would thus be maintained by the continuous presence of a sufficient reservoir of binding factors, rather than by persistence of nondissociable complexes. Any given active gene at any given moment might be disengaged from its regulatory factors and re-engaged the next moment and, thus, with respect to dissociation of active complexes, DNA replication might not be a particularly unique event. In an equilibrium system, control would be dynamic rather than exclusively structural, and the cessation or quantitative modulation of activity might be governed, with a brief time lag dependent only on complex half-life, by an increase or decrease in the ambient concentration of active factor.
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